A decision-ready blueprint
A technology-transfer and commercialisation solution designed around the commercial realities of academic technology transfer offices and research centers.
Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.
Academic medical and translational centres often need to move a selected research asset, platform, process, or programme from scientific promise into a more actionable transfer and commercialisation pathway. That requires more than gathering documents. The relevant evidence, dependencies, owners, and external-facing boundaries need to be visible to the people accountable for the next decision.
Lonrú Consulting designs the practical workflow around that work. We help research, technology-transfer, operational, and institutional teams establish a clearer readiness view, organise the information that needs review, and create an accountable route to the next technical, commercial, licensing, or partner action.
We define the approved research, process, IP, technical, operational, regulatory, partner, and institutional inputs relevant to the selected transfer or commercialisation question, together with ownership and information-sharing boundaries.
Configured systems can structure approved material, identify defined dependencies or information gaps, prepare readiness views, or assemble review-ready content within the agreed controls.
Lonrú provides principal-led workflow design, commercial framing, and review governance. Research leads, technology-transfer professionals, technical and operational owners, and client-selected specialists review work within their areas of accountability.
Approved outputs are delivered through a readiness tracker, evidence map, transfer workspace, partner interface, or executive decision view suited to the selected workflow.
Bring the selected scientific, technical, IP, operating, and commercial evidence into a practical view of what is ready, what remains uncertain, and what needs attention next.
Map the information, decisions, and accountable owners that connect research, technology transfer, operations, external partners, and institutional governance.
Organise approved evidence, technical context, IP information, and open questions for the relevant internal review before external engagement begins.
Create a usable decision environment for selected readiness, partnering, licensing, or implementation questions without presenting an early workflow as a replacement for established systems.
The work can prepare and clarify the evidence, dependencies, and review route around a selected transfer or commercialisation decision. It does not replace research ownership, technical authority, quality approval, IP governance, or institutional decision-making.
We agree which information can be used, who reviews it, and what may be shared externally before a partner workspace, interface, or automated preparation workflow is introduced.
Relevant experience
Preclinical to IND
Created interactive Preclinical-to-IND decision-tree frameworks and risk-mitigation reports to help advanced-therapy enabling-technology companies align product capabilities with FDA IND validation requirements and reduce preclinical translation delays.
Audit-ready
Formulated Technical Dossier Authoring frameworks that automate ingestion and structure of preclinical data pipelines for FDA IND and BLA submissions, producing organized, audit-ready regulatory dossiers.
Architecture in context
Diagram summary: Research, technical, IP, operational, partner, and institutional inputs are contextualised, analysed, and tested through ActiveArchitecture™ before they support a transfer-readiness or commercialisation decision.
Practical questions
Next step
Bring the decision, workflow, or delivery constraint that needs a clearer operating path.
Request a focused briefingTransfer questions we help clarify
A focused workstream connects the technical, operating, and commercial questions that need to be resolved before a transfer or commercialisation decision.